We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

28 hedge funds and large institutions have $3.26M invested in Zomedica Corp. in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

28% less funds holding

Funds holding: 3928 (-11)

41% less capital invested

Capital invested by funds: $5.55M → $3.26M (-$2.3M)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
28
Holders Change
-11
Holders Change %
-28.21%
% of All Funds
0.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
10
Reduced
7
Closed
15
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q2 2019 in Review

28 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2019, worth a combined $3.26M — down 41% from $5.55M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ZOM and 6 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 10 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $122K. The largest seller was BlackRock, exiting entirely with an estimated $610K sold.

  • 28 institutional investors held Zomedica Corp. (ZOM) as of Q2 2019, down from 39 in Q1 2019.
  • Funds reported $3.26M of Zomedica Corp. stock for Q2 2019, down 41% quarter-over-quarter.
  • 6 funds opened new Zomedica Corp. positions in Q2 2019 and 15 closed out, a net change of -9 holders.
  • The largest Zomedica Corp. buyer in Q2 2019 was Millennium Management, an estimated $122K added.
  • The largest Zomedica Corp. seller in Q2 2019 was BlackRock, an estimated $610K sold.

Based on aggregated 13F filings for Q2 2019.